Haleon

GSK Spins Off Consumer Health Business Worth Up To $57bn

British drugmaker GSK will spin off its consumer health business Haleon worth up to an estimated £48 billion ($57 billion) on Monday in the biggest l...

Pfizer Set To Exit GSK's Consumer Health Arm After Spin-Off

Pfizer plans to exit its 32% stake in Haleon, its consumer health joint venture with British drugmaker GSK, after the business is spun off as an independen...

Enjoy unlimited digital access for 30 days
Get exclusive access to the latest grocery retail & FMCG news, interviews with industry leading executives, and expert analysis on the trends shaping the sector today
Enjoy unlimited digital access for 30 days
Enjoy unlimited digital access for 30 days
Get exclusive access to the latest grocery retail & FMCG news, interviews with industry leading executives, and expert analysis on the trends shaping the sector today
Enjoy unlimited digital access for 30 days

Copyright © 2022. All rights reserved. Developed by Square1 and powered by PublisherPlus.com